Valuation: Virbac

Market Cap 2.78B 3.18B 2.56B 2.38B 4.52B 303B 4.59B 30.69B 11.93B 149B 11.94B 11.69B 513B P/E 2026 *
16.6x
P/E 2027 * 14.7x
Enterprise Value 2.9B 3.32B 2.67B 2.49B 4.72B 316B 4.79B 32.02B 12.45B 155B 12.46B 12.19B 535B EV / Sales 2026 *
1.88x
EV / Sales 2027 * 1.71x
Free-Float
49.03%
Yield 2026 *
0.52%
Yield 2027 * 0.62%
1 week-2.78%
Current month+0.15%
1 month-2.21%
3 months-5.27%
6 months-5.81%
Current year-6.60%
1 week 328
Extreme 328
346
1 month 328
Extreme 328
358
3 years 241
Extreme 241
400
5 years 216.5
Extreme 216.5
446.5
Manager TitleAgeSince
Chief Executive Officer 46 31/08/2025
Chief Executive Officer 50 26/09/2024
Chief Operating Officer 64 31/12/2021
Director TitleAgeSince
Chairman 61 31/03/2006
Director/Board Member 68 27/07/2010
Director/Board Member 65 04/09/2017
Change 5-day change 1-year change 3-year change Capi.($)
+0.45%-2.94%-4.45%+28.88% 3.18B
+3.24%-1.70%-53.01%-56.06% 31.36B
+3.78%+1.75%+70.77%+149.25% 12.49B
+1.56%-4.08%-13.04%+5.09% 3.78B
+2.93%+7.60%+53.68%+27.83% 1.92B
+0.50%+2.89%-27.86%+18.36% 1.65B
+3.61%+4.95%+18.79%+141.72% 1.35B
+2.74%+9.39%-20.52%-11.63% 1.02B
-1.39%-2.21%-6.23%-23.04% 955M
+2.29%+5.22%-15.20%-47.08% 919M
Average +2.14%+2.25%+0.29%+23.33% 6.16B
Weighted average by Cap. +3.06%-0.80%-13.65%+7.07%

Financials

2026 *2027 *
Net sales 1.55B 1.77B 1.42B 1.32B 2.51B 168B 2.55B 17.06B 6.63B 82.79B 6.64B 6.5B 285B 1.64B 1.88B 1.51B 1.4B 2.66B 179B 2.7B 18.09B 7.03B 87.78B 7.04B 6.89B 302B
Net income 167M 191M 153M 143M 271M 18.19B 275M 1.84B 716M 8.94B 717M 702M 30.81B 190M 218M 175M 163M 309M 20.72B 314M 2.1B 816M 10.18B 817M 799M 35.09B
Net Debt 121M 138M 111M 104M 197M 13.18B 200M 1.33B 519M 6.48B 520M 508M 22.32B 26.49M 30.3M 24.35M 22.69M 43.04M 2.89B 43.7M 292M 114M 1.42B 114M 111M 4.89B
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
-
Date Price Change
03/07/26 €332.50 +0.45%
02/07/26 €331.00 +0.30%
01/07/26 €330.00 -0.60%
30/06/26 €332.00 -2.35%
29/06/26 €340.00 -0.58%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
332.00EUR
Average target price
412.88EUR
Spread / Average Target
+24.36%

Quarterly revenue - Rate of surprise